APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biosimulation Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biosimulation Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17407969035 June 2026198 pages

Choose your research edition.

Industry ResearchBiosimulation Software Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosimulation Software Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Biosimulation Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosimulation Software Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosimulation Software Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Biosimulation Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biosimulation Software include Certara, Simulations, Dassault Systèmes, Schrödinger, Advanced Chemistry, Chemical Computing, Rosa & Co., Genedata and Physiomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biosimulation Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biosimulation Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biosimulation Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biosimulation Software market size, projected growth trends, production technologies, key applications, and end-use industries.

Biosimulation Software Segment by Company

Certara

Simulations

Dassault Systèmes

Schrödinger

Advanced Chemistry

Chemical Computing

Rosa & Co.

Genedata

Physiomics

In Silico Biosciences

Allucent

OpenEye (Cadence)

Cellworks Group

VeriSIM Life

Netabolics SRL

Charnwood Discovery

The MathWorks

ANSYS

Instem Group of Companies

Insilico Medicine

SCM

BioSymetrics

Atomwise

insitro

Clinithink

Biosimulation Software Segment by Type

Independent Modules

Integrated Software Platform

Biosimulation Software Segment by Application

Pharmaceuticals

Medical Research

Others

Biosimulation Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimulation Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosimulation Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimulation Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biosimulation Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biosimulation Software industry.

Chapter 3: Detailed analysis of Biosimulation Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimulation Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biosimulation Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Independent Modules Table 3. Key Players of Integrated Software Platform Table 4. Global Biosimulation Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceuticals Table 6. Key Players of Medical Research Table 7. Key Players of Others Table 8. Global Biosimulation Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Biosimulation Software Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Biosimulation Software Market Share by Region (2021-2026) Table 11. Global Biosimulation Software Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Biosimulation Software Market Share by Region (2027-2032) Table 13. Biosimulation Software Industry Trends Table 14. Biosimulation Software Industry Drivers Table 15. Biosimulation Software Industry Opportunities and Challenges Table 16. Biosimulation Software Industry Restraints Table 17. Global Biosimulation Software Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Biosimulation Software Revenue Market Share by Company (2021-2026) Table 19. Global Biosimulation Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Biosimulation Software Key Company Head Office and Area Served Table 21. Global Biosimulation Software Company, Product Type & Application Table 22. Global Biosimulation Software Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Biosimulation Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Biosimulation Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biosimulation Software Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Biosimulation Software Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Biosimulation Software Revenue Market Share by Type (2021-2026) Table 29. Global Biosimulation Software Revenue Market Share by Type (2027-2032) Table 30. Global Biosimulation Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biosimulation Software Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Biosimulation Software Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Biosimulation Software Revenue Market Share by Application (2021-2026) Table 34. Global Biosimulation Software Revenue Market Share by Application (2027-2032) Table 35. Certara Company Information Table 36. Certara Business Overview Table 37. Certara Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Certara Biosimulation Software Product Portfolio Table 39. Certara Recent Development Table 40. Simulations Company Information Table 41. Simulations Business Overview Table 42. Simulations Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Simulations Biosimulation Software Product Portfolio Table 44. Simulations Recent Development Table 45. Dassault Systèmes Company Information Table 46. Dassault Systèmes Business Overview Table 47. Dassault Systèmes Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Dassault Systèmes Biosimulation Software Product Portfolio Table 49. Dassault Systèmes Recent Development Table 50. Schrödinger Company Information Table 51. Schrödinger Business Overview Table 52. Schrödinger Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Schrödinger Biosimulation Software Product Portfolio Table 54. Schrödinger Recent Development Table 55. Advanced Chemistry Company Information Table 56. Advanced Chemistry Business Overview Table 57. Advanced Chemistry Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Advanced Chemistry Biosimulation Software Product Portfolio Table 59. Advanced Chemistry Recent Development Table 60. Chemical Computing Company Information Table 61. Chemical Computing Business Overview Table 62. Chemical Computing Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Chemical Computing Biosimulation Software Product Portfolio Table 64. Chemical Computing Recent Development Table 65. Rosa & Co. Company Information Table 66. Rosa & Co. Business Overview Table 67. Rosa & Co. Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Rosa & Co. Biosimulation Software Product Portfolio Table 69. Rosa & Co. Recent Development Table 70. Genedata Company Information Table 71. Genedata Business Overview Table 72. Genedata Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Genedata Biosimulation Software Product Portfolio Table 74. Genedata Recent Development Table 75. Physiomics Company Information Table 76. Physiomics Business Overview Table 77. Physiomics Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Physiomics Biosimulation Software Product Portfolio Table 79. Physiomics Recent Development Table 80. In Silico Biosciences Company Information Table 81. In Silico Biosciences Business Overview Table 82. In Silico Biosciences Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. In Silico Biosciences Biosimulation Software Product Portfolio Table 84. In Silico Biosciences Recent Development Table 85. Allucent Company Information Table 86. Allucent Business Overview Table 87. Allucent Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Allucent Biosimulation Software Product Portfolio Table 89. Allucent Recent Development Table 90. OpenEye (Cadence) Company Information Table 91. OpenEye (Cadence) Business Overview Table 92. OpenEye (Cadence) Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. OpenEye (Cadence) Biosimulation Software Product Portfolio Table 94. OpenEye (Cadence) Recent Development Table 95. Cellworks Group Company Information Table 96. Cellworks Group Business Overview Table 97. Cellworks Group Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Cellworks Group Biosimulation Software Product Portfolio Table 99. Cellworks Group Recent Development Table 100. VeriSIM Life Company Information Table 101. VeriSIM Life Business Overview Table 102. VeriSIM Life Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. VeriSIM Life Biosimulation Software Product Portfolio Table 104. VeriSIM Life Recent Development Table 105. Netabolics SRL Company Information Table 106. Netabolics SRL Business Overview Table 107. Netabolics SRL Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Netabolics SRL Biosimulation Software Product Portfolio Table 109. Netabolics SRL Recent Development Table 110. Charnwood Discovery Company Information Table 111. Charnwood Discovery Business Overview Table 112. Charnwood Discovery Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Charnwood Discovery Biosimulation Software Product Portfolio Table 114. Charnwood Discovery Recent Development Table 115. The MathWorks Company Information Table 116. The MathWorks Business Overview Table 117. The MathWorks Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. The MathWorks Biosimulation Software Product Portfolio Table 119. The MathWorks Recent Development Table 120. ANSYS Company Information Table 121. ANSYS Business Overview Table 122. ANSYS Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. ANSYS Biosimulation Software Product Portfolio Table 124. ANSYS Recent Development Table 125. Instem Group of Companies Company Information Table 126. Instem Group of Companies Business Overview Table 127. Instem Group of Companies Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Instem Group of Companies Biosimulation Software Product Portfolio Table 129. Instem Group of Companies Recent Development Table 130. Insilico Medicine Company Information Table 131. Insilico Medicine Business Overview Table 132. Insilico Medicine Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Insilico Medicine Biosimulation Software Product Portfolio Table 134. Insilico Medicine Recent Development Table 135. SCM Company Information Table 136. SCM Business Overview Table 137. SCM Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. SCM Biosimulation Software Product Portfolio Table 139. SCM Recent Development Table 140. BioSymetrics Company Information Table 141. BioSymetrics Business Overview Table 142. BioSymetrics Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. BioSymetrics Biosimulation Software Product Portfolio Table 144. BioSymetrics Recent Development Table 145. Atomwise Company Information Table 146. Atomwise Business Overview Table 147. Atomwise Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 148. Atomwise Biosimulation Software Product Portfolio Table 149. Atomwise Recent Development Table 150. insitro Company Information Table 151. insitro Business Overview Table 152. insitro Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 153. insitro Biosimulation Software Product Portfolio Table 154. insitro Recent Development Table 155. Clinithink Company Information Table 156. Clinithink Business Overview Table 157. Clinithink Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 158. Clinithink Biosimulation Software Product Portfolio Table 159. Clinithink Recent Development Table 160. North America Biosimulation Software Market Size by Type (2021-2026) & (US$ Million) Table 161. North America Biosimulation Software Market Size by Type (2027-2032) & (US$ Million) Table 162. North America Biosimulation Software Market Size by Application (2021-2026) & (US$ Million) Table 163. North America Biosimulation Software Market Size by Application (2027-2032) & (US$ Million) Table 164. North America Biosimulation Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. North America Biosimulation Software Market Size by Country (2021-2026) Table 166. North America Biosimulation Software Market Size by Country (2027-2032) Table 167. Europe Biosimulation Software Market Size by Type (2021-2026) & (US$ Million) Table 168. Europe Biosimulation Software Market Size by Type (2027-2032) & (US$ Million) Table 169. Europe Biosimulation Software Market Size by Application (2021-2026) & (US$ Million) Table 170. Europe Biosimulation Software Market Size by Application (2027-2032) & (US$ Million) Table 171. Europe Biosimulation Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Europe Biosimulation Software Market Size by Country (2021-2026) Table 173. Europe Biosimulation Software Market Size by Country (2027-2032) Table 174. China Biosimulation Software Market Size by Type (2021-2026) & (US$ Million) Table 175. China Biosimulation Software Market Size by Type (2027-2032) & (US$ Million) Table 176. China Biosimulation Software Market Size by Application (2021-2026) & (US$ Million) Table 177. China Biosimulation Software Market Size by Application (2027-2032) & (US$ Million) Table 178. Asia Biosimulation Software Market Size by Type (2021-2026) & (US$ Million) Table 179. Asia Biosimulation Software Market Size by Type (2027-2032) & (US$ Million) Table 180. Asia Biosimulation Software Market Size by Application (2021-2026) & (US$ Million) Table 181. Asia Biosimulation Software Market Size by Application (2027-2032) & (US$ Million) Table 182. Asia Biosimulation Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Asia Biosimulation Software Market Size by Country (2021-2026) Table 184. Asia Biosimulation Software Market Size by Country (2027-2032) Table 185. South America, Middle East & Africa Biosimulation Software Market Size by Type (2021-2026) & (US$ Million) Table 186. South America, Middle East & Africa Biosimulation Software Market Size by Type (2027-2032) & (US$ Million) Table 187. South America, Middle East & Africa Biosimulation Software Market Size by Application (2021-2026) & (US$ Million) Table 188. South America, Middle East & Africa Biosimulation Software Market Size by Application (2027-2032) & (US$ Million) Table 189. South America, Middle East & Africa Biosimulation Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. South America, Middle East & Africa Biosimulation Software Market Size by Country (2021-2026) Table 191. South America, Middle East & Africa Biosimulation Software Market Size by Country (2027-2032) Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Biosimulation Software Product Image Figure 2. Global Biosimulation Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biosimulation Software Market Share by Type: 2025 VS 2032 Figure 4. Independent Modules Image Figure 5. Integrated Software Platform Image Figure 6. Global Biosimulation Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Biosimulation Software Market Share by Application: 2025 VS 2032 Figure 8. Pharmaceuticals Image Figure 9. Medical Research Image Figure 10. Others Image Figure 11. Global Biosimulation Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 13. Global Biosimulation Software Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Biosimulation Software Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Biosimulation Software Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Biosimulation Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biosimulation Software Revenue Market Share by Type (2021-2032) Figure 20. Global Biosimulation Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Biosimulation Software Revenue Market Share by Application (2021-2032) Figure 22. North America Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 23. North America Biosimulation Software Market Share by Type (2021-2032) Figure 24. North America Biosimulation Software Market Share by Application (2021-2032) Figure 25. North America Biosimulation Software Market Share by Country (2021-2032) Figure 26. United States Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 27. Canada Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 29. Europe Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 30. Europe Biosimulation Software Market Share by Type (2021-2032) Figure 31. Europe Biosimulation Software Market Share by Application (2021-2032) Figure 32. Europe Biosimulation Software Market Share by Country (2021-2032) Figure 33. Germany Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 34. France Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 36. Italy Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 37. Russia Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 39. China Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 40. China Biosimulation Software Market Share by Type (2021-2032) Figure 41. China Biosimulation Software Market Share by Application (2021-2032) Figure 42. Asia Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 43. Asia Biosimulation Software Market Share by Type (2021-2032) Figure 44. Asia Biosimulation Software Market Share by Application (2021-2032) Figure 45. Asia Biosimulation Software Market Share by Country (2021-2032) Figure 46. Japan Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 50. India Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 51. Australia Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Biosimulation Software Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Biosimulation Software Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Biosimulation Software Market Share by Country (2021-2032) Figure 56. Brazil Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 61. UAE Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 63. Chile Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Independent Modules
  • Integrated Software Platform
Applications
  • Pharmaceuticals
  • Medical Research
  • Others
Companies covered
  • Certara
  • Simulations
  • Dassault Systèmes
  • Schrödinger
  • Advanced Chemistry
  • Chemical Computing
  • Rosa & Co.
  • Genedata
  • Physiomics
  • In Silico Biosciences
  • Allucent
  • OpenEye (Cadence)
  • Cellworks Group
  • VeriSIM Life
  • Netabolics SRL
  • Charnwood Discovery
  • The MathWorks
  • ANSYS
  • Instem Group of Companies
  • Insilico Medicine
  • SCM
  • BioSymetrics
  • Atomwise
  • insitro
  • Clinithink

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biosimulation Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Independent Modules
  5. 1.2.3 Integrated Software Platform
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Biosimulation Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceuticals
  9. 1.3.3 Medical Research
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Biosimulation Software Growth Trends by Region
  13. 1.5.1 Global Biosimulation Software Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Biosimulation Software Market Size by Region (2021-2026)
  15. 1.5.3 Biosimulation Software Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Biosimulation Software Market Dynamics
  1. 2.1 Biosimulation Software Industry Trends
  2. 2.2 Biosimulation Software Industry Drivers
  3. 2.3 Biosimulation Software Industry Opportunities and Challenges
  4. 2.4 Biosimulation Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biosimulation Software Revenue by Company (2021-2026)
  2. 3.2 Global Biosimulation Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biosimulation Software Key Company Head office and Area Served
  4. 3.4 Global Biosimulation Software Company, Product Type & Application
  5. 3.5 Global Biosimulation Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biosimulation Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biosimulation Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biosimulation Software Tier 1, Tier 2, and Tier 3
4 Biosimulation Software Market by Type
  1. 4.1 Global Biosimulation Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biosimulation Software Market Size by Type (2021-2032)
  3. 4.3 Global Biosimulation Software Market Size Share by Type (2021-2032)
5 Biosimulation Software Market by Application
  1. 5.1 Global Biosimulation Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biosimulation Software Market Size by Application (2021-2032)
  3. 5.3 Global Biosimulation Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Certara
  2. 6.1.1 Certara Company Information
  3. 6.1.2 Certara Business Overview
  4. 6.1.3 Certara Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Certara Biosimulation Software Product Portfolio
  6. 6.1.5 Certara Recent Developments
  7. 6.2 Simulations
  8. 6.2.1 Simulations Company Information
  9. 6.2.2 Simulations Business Overview
  10. 6.2.3 Simulations Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Simulations Biosimulation Software Product Portfolio
  12. 6.2.5 Simulations Recent Developments
  13. 6.3 Dassault Systèmes
  14. 6.3.1 Dassault Systèmes Company Information
  15. 6.3.2 Dassault Systèmes Business Overview
  16. 6.3.3 Dassault Systèmes Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Dassault Systèmes Biosimulation Software Product Portfolio
  18. 6.3.5 Dassault Systèmes Recent Developments
  19. 6.4 Schrödinger
  20. 6.4.1 Schrödinger Company Information
  21. 6.4.2 Schrödinger Business Overview
  22. 6.4.3 Schrödinger Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Schrödinger Biosimulation Software Product Portfolio
  24. 6.4.5 Schrödinger Recent Developments
  25. 6.5 Advanced Chemistry
  26. 6.5.1 Advanced Chemistry Company Information
  27. 6.5.2 Advanced Chemistry Business Overview
  28. 6.5.3 Advanced Chemistry Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Advanced Chemistry Biosimulation Software Product Portfolio
  30. 6.5.5 Advanced Chemistry Recent Developments
  31. 6.6 Chemical Computing
  32. 6.6.1 Chemical Computing Company Information
  33. 6.6.2 Chemical Computing Business Overview
  34. 6.6.3 Chemical Computing Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Chemical Computing Biosimulation Software Product Portfolio
  36. 6.6.5 Chemical Computing Recent Developments
  37. 6.7 Rosa & Co.
  38. 6.7.1 Rosa & Co. Company Information
  39. 6.7.2 Rosa & Co. Business Overview
  40. 6.7.3 Rosa & Co. Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Rosa & Co. Biosimulation Software Product Portfolio
  42. 6.7.5 Rosa & Co. Recent Developments
  43. 6.8 Genedata
  44. 6.8.1 Genedata Company Information
  45. 6.8.2 Genedata Business Overview
  46. 6.8.3 Genedata Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Genedata Biosimulation Software Product Portfolio
  48. 6.8.5 Genedata Recent Developments
  49. 6.9 Physiomics
  50. 6.9.1 Physiomics Company Information
  51. 6.9.2 Physiomics Business Overview
  52. 6.9.3 Physiomics Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Physiomics Biosimulation Software Product Portfolio
  54. 6.9.5 Physiomics Recent Developments
  55. 6.10 In Silico Biosciences
  56. 6.10.1 In Silico Biosciences Company Information
  57. 6.10.2 In Silico Biosciences Business Overview
  58. 6.10.3 In Silico Biosciences Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 In Silico Biosciences Biosimulation Software Product Portfolio
  60. 6.10.5 In Silico Biosciences Recent Developments
  61. 6.11 Allucent
  62. 6.11.1 Allucent Company Information
  63. 6.11.2 Allucent Business Overview
  64. 6.11.3 Allucent Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Allucent Biosimulation Software Product Portfolio
  66. 6.11.5 Allucent Recent Developments
  67. 6.12 OpenEye (Cadence)
  68. 6.12.1 OpenEye (Cadence) Company Information
  69. 6.12.2 OpenEye (Cadence) Business Overview
  70. 6.12.3 OpenEye (Cadence) Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 OpenEye (Cadence) Biosimulation Software Product Portfolio
  72. 6.12.5 OpenEye (Cadence) Recent Developments
  73. 6.13 Cellworks Group
  74. 6.13.1 Cellworks Group Company Information
  75. 6.13.2 Cellworks Group Business Overview
  76. 6.13.3 Cellworks Group Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Cellworks Group Biosimulation Software Product Portfolio
  78. 6.13.5 Cellworks Group Recent Developments
  79. 6.14 VeriSIM Life
  80. 6.14.1 VeriSIM Life Company Information
  81. 6.14.2 VeriSIM Life Business Overview
  82. 6.14.3 VeriSIM Life Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 VeriSIM Life Biosimulation Software Product Portfolio
  84. 6.14.5 VeriSIM Life Recent Developments
  85. 6.15 Netabolics SRL
  86. 6.15.1 Netabolics SRL Company Information
  87. 6.15.2 Netabolics SRL Business Overview
  88. 6.15.3 Netabolics SRL Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Netabolics SRL Biosimulation Software Product Portfolio
  90. 6.15.5 Netabolics SRL Recent Developments
  91. 6.16 Charnwood Discovery
  92. 6.16.1 Charnwood Discovery Company Information
  93. 6.16.2 Charnwood Discovery Business Overview
  94. 6.16.3 Charnwood Discovery Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Charnwood Discovery Biosimulation Software Product Portfolio
  96. 6.16.5 Charnwood Discovery Recent Developments
  97. 6.17 The MathWorks
  98. 6.17.1 The MathWorks Company Information
  99. 6.17.2 The MathWorks Business Overview
  100. 6.17.3 The MathWorks Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 The MathWorks Biosimulation Software Product Portfolio
  102. 6.17.5 The MathWorks Recent Developments
  103. 6.18 ANSYS
  104. 6.18.1 ANSYS Company Information
  105. 6.18.2 ANSYS Business Overview
  106. 6.18.3 ANSYS Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 ANSYS Biosimulation Software Product Portfolio
  108. 6.18.5 ANSYS Recent Developments
  109. 6.19 Instem Group of Companies
  110. 6.19.1 Instem Group of Companies Company Information
  111. 6.19.2 Instem Group of Companies Business Overview
  112. 6.19.3 Instem Group of Companies Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Instem Group of Companies Biosimulation Software Product Portfolio
  114. 6.19.5 Instem Group of Companies Recent Developments
  115. 6.20 Insilico Medicine
  116. 6.20.1 Insilico Medicine Company Information
  117. 6.20.2 Insilico Medicine Business Overview
  118. 6.20.3 Insilico Medicine Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Insilico Medicine Biosimulation Software Product Portfolio
  120. 6.20.5 Insilico Medicine Recent Developments
  121. 6.21 SCM
  122. 6.21.1 SCM Company Information
  123. 6.21.2 SCM Business Overview
  124. 6.21.3 SCM Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 SCM Biosimulation Software Product Portfolio
  126. 6.21.5 SCM Recent Developments
  127. 6.22 BioSymetrics
  128. 6.22.1 BioSymetrics Company Information
  129. 6.22.2 BioSymetrics Business Overview
  130. 6.22.3 BioSymetrics Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 BioSymetrics Biosimulation Software Product Portfolio
  132. 6.22.5 BioSymetrics Recent Developments
  133. 6.23 Atomwise
  134. 6.23.1 Atomwise Company Information
  135. 6.23.2 Atomwise Business Overview
  136. 6.23.3 Atomwise Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Atomwise Biosimulation Software Product Portfolio
  138. 6.23.5 Atomwise Recent Developments
  139. 6.24 insitro
  140. 6.24.1 insitro Company Information
  141. 6.24.2 insitro Business Overview
  142. 6.24.3 insitro Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 insitro Biosimulation Software Product Portfolio
  144. 6.24.5 insitro Recent Developments
  145. 6.25 Clinithink
  146. 6.25.1 Clinithink Company Information
  147. 6.25.2 Clinithink Business Overview
  148. 6.25.3 Clinithink Biosimulation Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Clinithink Biosimulation Software Product Portfolio
  150. 6.25.5 Clinithink Recent Developments
7 North America
  1. 7.1 North America Biosimulation Software Market Size (2021-2032)
  2. 7.2 North America Biosimulation Software Market Size by Type
  3. 7.2.1 North America Biosimulation Software Market Size by Type (2021-2026)
  4. 7.2.2 North America Biosimulation Software Market Size by Type (2027-2032)
  5. 7.2.3 North America Biosimulation Software Market Share by Type (2021-2032)
  6. 7.3 North America Biosimulation Software Market Size by Application
  7. 7.3.1 North America Biosimulation Software Market Size by Application (2021-2026)
  8. 7.3.2 North America Biosimulation Software Market Size by Application (2027-2032)
  9. 7.3.3 North America Biosimulation Software Market Share by Application (2021-2032)
  10. 7.4 North America Biosimulation Software Market Size by Country
  11. 7.4.1 North America Biosimulation Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biosimulation Software Market Size by Country (2021-2026)
  13. 7.4.3 North America Biosimulation Software Market Size by Country (2027-2032)
  14. 7.4.4 North America Biosimulation Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biosimulation Software Market Size (2021-2032)
  2. 8.2 Europe Biosimulation Software Market Size by Type
  3. 8.2.1 Europe Biosimulation Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biosimulation Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biosimulation Software Market Share by Type (2021-2032)
  6. 8.3 Europe Biosimulation Software Market Size by Application
  7. 8.3.1 Europe Biosimulation Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biosimulation Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biosimulation Software Market Share by Application (2021-2032)
  10. 8.4 Europe Biosimulation Software Market Size by Country
  11. 8.4.1 Europe Biosimulation Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biosimulation Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biosimulation Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biosimulation Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biosimulation Software Market Size (2021-2032)
  2. 9.2 China Biosimulation Software Market Size by Type
  3. 9.2.1 China Biosimulation Software Market Size by Type (2021-2026)
  4. 9.2.2 China Biosimulation Software Market Size by Type (2027-2032)
  5. 9.2.3 China Biosimulation Software Market Share by Type (2021-2032)
  6. 9.3 China Biosimulation Software Market Size by Application
  7. 9.3.1 China Biosimulation Software Market Size by Application (2021-2026)
  8. 9.3.2 China Biosimulation Software Market Size by Application (2027-2032)
  9. 9.3.3 China Biosimulation Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biosimulation Software Market Size (2021-2032)
  2. 10.2 Asia Biosimulation Software Market Size by Type
  3. 10.2.1 Asia Biosimulation Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biosimulation Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biosimulation Software Market Share by Type (2021-2032)
  6. 10.3 Asia Biosimulation Software Market Size by Application
  7. 10.3.1 Asia Biosimulation Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biosimulation Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biosimulation Software Market Share by Application (2021-2032)
  10. 10.4 Asia Biosimulation Software Market Size by Country
  11. 10.4.1 Asia Biosimulation Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biosimulation Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biosimulation Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biosimulation Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biosimulation Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biosimulation Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biosimulation Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biosimulation Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biosimulation Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biosimulation Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biosimulation Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biosimulation Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biosimulation Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biosimulation Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biosimulation Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biosimulation Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biosimulation Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biosimulation Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst